Articles

Non-invasive prenatal testing (NIPT) screens for common chromosomal abnormalities from cell-free fetal DNA in the mother's blood from the 10th week of pregnancy.

About 5 to 10% of all cancers are hereditary. Genetic panels identify the mutations that raise risk based on personal and family history, guiding follow-up and prevention plans.

Genetic differences change the effect and side-effect risk of many drugs. Pharmacogenetic tests help personalize treatment choice and dosing.

PGT allows embryos to be examined for specific genetic conditions before they are transferred to the uterus during IVF.

The exome is the protein-coding part of the genome, and most disease-causing variants are found there. WES is a powerful tool for undiagnosed rare diseases.